eCential Robotics secured €10.7M in series B funding backed by Bpifrance and Sigma Gestion

eCential Robotics, a Grenoble, France-based developer of 2D/3D imaging technologies integrating surgical navigation, announced securing a €10.7 million ($13.1M) Series B financing round.

The money was raised from investors from France led by BpiFrance via the PSIM (Major Innovation Support Program) fund, and by Sigma Gestion.

Stéphane Lavallée, founder, also contributed to the round, alongside other existing investors.

The funds will be used for the commercial deployment of its imaging system with integrated surgical navigation.

eCential Robotics, founded as Surgivisio by Stéphane Lavallée, develops 2D and 3D imaging solutions with integrated navigation to assist surgeons in performing multiple procedures, particularly on the spine. Led by Laurence van Beek and David Armand, Surgivisio’s R & D team will focus on the application for spine surgery, before addressing other segments of orthopedics and traumatology. Protected by more than 19 patents, the device is a highend equipment for advanced healthcare facilities, which has been CE marked by the G-MED (0459) and is now marketed in Europe.

The company is working on the industrialization of its production and the development of its network of distributors and partners, as well as approval from the US regulatory agency, the Food and Drug Administration (FDA), to address the US market.